SLHN Stock Analysis: Swiss Life Holding | SW
Insurance - Diversified | SW, Switzerland | Market Cap: 25.296m CHF | 12M Return: 14.8% | CH0014852781 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 48.4M
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Swiss Life Holding AG is a Swiss-headquartered insurance and financial services group that provides life, pension, health, annuity, and investment-type products to both individual and corporate clients. The company also offers property and casualty, liability, motor, accident, and payment protection insurance, and complements these with asset management, advisory, and investment fund services.
Its operations are organized across Switzerland, France, Germany, International, Asset Managers, and Other segments, with additional presence in the United Kingdom and Luxembourg. Products are distributed through proprietary sales channels and partners under brands such as Swiss Life Select, Tecis, Horbach, Proventus, and Chase de Vere.
As a multi-line insurance company, Swiss Life generates the bulk of its revenue from premiums and fees on life and pension policies, while investment income from its managed assets is another key earnings driver. The company was founded in 1857 and is based in Zurich.
- ECB and SNB rate cuts pressure life insurance investment margins
- Asset Managers fee income grows on rising AUM
- Share buyback program supports earnings per share growth
| Net Income: 1.29b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.39 > 1.0 |
| NWC/Revenue: -794.3% < 20% (prev -1.79k%; Δ 994.1% < -1%) |
| CFO/TA 0.01 > 3% & CFO 1.89b > Net Income 1.29b |
| Net Debt (11.5b) to EBITDA (1.74b): 6.61 < 3 |
| Current Ratio: 0.04 > 1.5 & < 3 |
| Outstanding Shares: last quarter (28.0m) vs 12m ago -3.40% < -2% |
| Gross Margin: 81.01% > 18% (prev 100.0%; Δ -18.99% > 0.5%) |
| Asset Turnover: 9.06% > 50% (prev 2.69%; Δ 6.37% > 0%) |
| Interest Coverage Ratio: 6.29 > 6 (EBIT TTM 1.74b / Interest Expense TTM 276.0m) |
| A: -0.70 (Total Current Assets 6.99b - Total Current Liabilities 166b) / Total Assets 227b |
| B: 0.04 (Retained Earnings 8.63b / Total Assets 227b) |
| C: 0.01 (EBIT TTM 1.74b / Avg Total Assets 221b) |
| D: 0.03 (Book Value of Equity 6.31b / Total Liabilities 220b) |
| Altman-Z'' = -4.40 = D |
| DSRI: 0.22 (Receivables 1.95b/2.61b, Revenue 20.1b/5.82b) |
| GMI: 1.23 (GM 100.0% / 81.01%) |
| AQI: 1.34 (AQ_t 0.96 / AQ_t-1 0.72) |
| SGI: 3.45 (Revenue 20.1b / 5.82b) |
| TATA: -0.00 (NI 1.29b - CFO 1.89b) / TA 227b) |
| Beneish M = -1.50 (Cap -4..+1) = CCC |
As of September 27, 2026, the stock is trading at CHF 915.80 with a total of 50,605 shares traded. Over the past week, the price has changed by -0.91%, over one month by -0.56%, over three months by +3.76% and over the past year by +14.81%.
Current recommended Stop Loss: 888.30 (which is 3% or 2.1 ATR below the current price).
Swiss Life Holding has no consensus analysts rating.
P/E Trailing = 19.9603
P/E Forward = 17.762
P/S = 2.1247
P/B = 4.0561
P/EG = 2.3068
Revenue TTM = 20.1b CHF
EBIT TTM = 1.74b CHF
EBITDA TTM = 1.74b CHF
Long Term Debt = 10.3b CHF (from longTermDebt, last quarter)
Short Term Debt = 5.78b CHF (from shortTermDebt, last quarter)
Debt = 16.5b CHF (from shortLongTermDebtTotal, last quarter) + Leases 215.0m
Net Debt = 11.5b CHF (calculated: Debt 16.5b - CCE 5.04b)
Enterprise Value = 36.8b CHF (25.3b + Debt 16.5b - CCE 5.04b)
Interest Coverage Ratio = 6.29 (Ebit TTM 1.74b / Interest Expense TTM 276.0m)
EV/FCF = 20.42x (Enterprise Value 36.8b / FCF TTM 1.80b)
FCF Yield = 4.90% (FCF TTM 1.80b / Enterprise Value 36.8b)
FCF Margin = 8.98% (FCF TTM 1.80b / Revenue TTM 20.1b)
Net Margin = 6.44% (Net Income TTM 1.29b / Revenue TTM 20.1b)
Gross Margin = 81.01% ((Revenue TTM 20.1b - Cost of Revenue TTM 3.81b) / Revenue TTM)
Gross Margin QoQ = 50.63% (prev none%)
Tobins Q-Ratio = 0.16 (Enterprise Value 36.8b / Total Assets 227b)
Interest Expense / Debt = 1.67% (Interest Expense 276.0m / Debt 16.5b)
Taxrate = 24.99% (434.0m / 1.74b)
NOPAT = 1.30b (EBIT 1.74b * (1 - 24.99%))
Current Ratio = 0.04 (Total Current Assets 6.99b / Total Current Liabilities 166b)
Debt / Equity = 2.62 (Debt 16.5b / totalStockholderEquity, last quarter 6.31b)
Debt / EBITDA = 6.61 (Net Debt 11.5b / EBITDA 1.74b)
Debt / FCF = 6.37 (Net Debt 11.5b / FCF TTM 1.80b)
Total Stockholder Equity = 6.93b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.58% (Net Income 1.29b / Total Assets 227b)
RoE = 18.64% (Net Income TTM 1.29b / Total Stockholder Equity 6.93b)
RoCE = 10.07% (EBIT 1.74b / Capital Employed (Equity 6.93b + L.T.Debt 10.3b))
RoIC = 2.00% (NOPAT 1.30b / Invested Capital 65.1b)
WACC = 4.26% (E(25.3b)/V(41.8b) * Re(6.23%) + D(16.5b)/V(41.8b) * Rd(1.67%) * (1-Tc(0.25)))
Discount Rate = 6.23% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -92.56 | Cagr: -4.33%
[DCF] Terminal Value 77.97% ; FCFF base≈1.43b ; Y1≈1.64b ; Y5≈2.41b
[DCF] Fair Price = 886.3 (EV 36.2b - Net Debt 11.5b = Equity 24.8b / Shares 27.9m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.0 | # QB: 0
Revenue Correlation: 8.83 | Revenue CAGR: 4.18% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=47.66 | Chg30d=+0.82% | Revisions=+12% | GrowthEPS=+9.6% | GrowthRev=+2.6%
EPS next Year (2027-12-31): EPS=51.33 | Chg30d=+0.73% | Revisions=+12% | GrowthEPS=+7.7% | GrowthRev=+3.5%
[Analyst] Revisions Ratio: +15% (up=6, down=4)